This product is intended exclusively for laboratory research purposes
However, native GLP-1 has a limited half-life (1.55 min) due to its degradation by the enzyme Dipeptidyl peptidase 4 (DPP-4), necessitating the development of GLP-1 receptor agonists (GLP-1RAs) with longer activity (Campbell and Drucker 2013)
In addition to laboratory investigations, the clinical aspects comprising patient risk factors, geographical prevalence, and age of presentation, alongside physical examination and an appropriate history-taking, can help to establish the diagnosis [1]
Improved glycemic control also reduces glucose-mediated nerve damage, which could lessen neuropathic symptoms over time
4 Peptides Combined 25mg Total Active Dose Multi Pathway Synergy Complete Healing System Blend Components Each vial contains precisely calibrated doses of TB-500, BPC-157, KPV, and GHK-Cu working synergistically for comprehensive healing and regeneration